Company profile

Ardelyx, Inc. Tech Stack

Commercial-stage biopharma marketing tenapanor-based GI and kidney therapies

Biotechnology Research Waltham, MA 201–500 employees Founded 2007 Public Company

Ardelyx is a Waltham-based biopharma with two US-approved tenapanor products and a pipeline built around NHE3 inhibition. Hiring is accelerating and director-heavy, concentrated in sales, quality and manufacturing, which points to commercial expansion backed by tighter oversight of outsourced production. Its stack pairs Veeva CRM and Veeva RIM with NetSuite, Medidata and a Microsoft security suite (Defender XDR, Sentinel, Purview), the profile of a regulated commercial operation running on Azure and AWS.

Tech Stack 21 technologies

Core StackNetSuite Smartsheet Tableau SAS Workday SAP Oracle Salesforce AWS Veeva CRM Veeva Medidata LIMS Paylocity Tilt Veeva RIM Microsoft Defender XDR Microsoft Sentinel Microsoft Purview Azure Azure Logic Apps

What Ardelyx, Inc. Is BuildingChallenges and projects from their job posts

◆Challenges

Patient access and coverage barriers
Maintaining regulatory inspection readiness
Managing external partner quality risk and issues
Maintaining supply commitments
Competing in crowded therapeutic markets
Improving logistics processes continuously

▲Active Projects

First-in-class product launch and promotion
Manufacturing technology transfer
Implementing new ERP functionalities
Annual risk-based internal audit program
Quality agreement lifecycle and alliance partner governance
Annual product quality reviews and validation

Hiring Activity

Accelerating25 roles · 15 in 30d

Department

Sales

Quality

Manufacturing

Ops

Finance

Healthcare

Logistics

Seniority

Director

Senior

Manager

Mid

Notable leadership hires: Business Director

Companies like Ardelyx, Inc.

200+ Biotechnology Research companies running NetSuite

See the full list

About Ardelyx, Inc.

Ardelyx, Inc. is a public, commercial-stage biopharmaceutical company founded in 2007 and headquartered in Waltham, MA. It markets two tenapanor-based medicines in the United States, IBSRELA and XPHOZAH. Its pipeline includes a Phase 3 program for IBSRELA in chronic idiopathic constipation and RDX10531, a next-generation NHE3 inhibitor. Outside the US, Ardelyx develops and commercializes its products through partners. The company has 201–500 employees, and its current hiring is focused on the United States.

HeadquartersWaltham, MA

Company Size201–500 employees

Founded2007

Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does Ardelyx use?

Ardelyx uses Veeva CRM, Veeva RIM, NetSuite, Medidata, SAS, LIMS, Tableau, Smartsheet, Workday, Salesforce and SAP. Its infrastructure runs on Azure and AWS, and Microsoft Defender XDR, Sentinel and Purview cover security.

Is Ardelyx hiring sales and quality roles?

Yes. Hiring at Ardelyx is accelerating, led by sales, quality and manufacturing, with a heavy share of director-level openings. All roles are based in the United States.

What is Ardelyx working on?

Job posts point to technology transfer, a first-in-class product launch, a risk-based internal audit program, quality agreement lifecycle management and new ERP functionality.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

Quanterix

Biotechnology Research

Rhythm Pharmaceuticals Inc.

Biotechnology Research

Geneoscopy

Biotechnology Research

Praxis Precision Medicines, Inc.

Biotechnology Research

How this profile is built

Ardelyx, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.